Alamar Biosciences, Inc.
ALMRNasdaqCIK 2104204TechnologyFiscal year ends Dec 31
Reports and events: 13 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-0116:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-378360 |
| 2026-08-1120:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-343003 |
| 2026-08-1016:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-342378 |
| 2026-07-1516:04 ET | 8-K | 8.01 Other events | 0001193125-26-304736 |
| 2026-07-0716:55 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001875620-26-000010 |
| 2026-05-0808:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-213424 |
| 2026-05-0808:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-213379 |
| 2026-04-2316:24 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-26-173780 |
| 2026-04-2313:57 ET | SCHEDULE 13D | Ownership report, active investor | 0001875620-26-000007 |
| 2026-04-2016:02 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-163921 |
| 2026-04-1609:25 ET | S-1/A | Registration statement, amended | 0001193125-26-158122 |
| 2026-04-1306:05 ET | S-1/A | Registration statement, amended | 0001193125-26-151891 |
| 2026-03-2716:12 ET | S-1 | Registration statement | 0001193125-26-129039 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:10 ET. Listed shows no prices and gives no investment advice.